Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure

Author： Chirkov Yuliy Sciscio Michele Sverdlov Aaron Leslie Sue Sage Peter Horowitz John

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.2, 2010-04, pp. : 131-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Antagonism of Aldosterone Receptor Prevents the Development of Hypertensive Heart Failure Induced by Chronic Inhibition of Nitric Oxide Synthesis in Rats

By Tsukamoto Osamu Minamino Tetsuo Sanada Shoji Okada Ken-ichiro Hirata Akio Fujita Masashi Shintani Yasunori Yulin Liao Asano Yoshihiro Takashima Seiji Yamasaki Satoru Tomoike Hitonobu Hori Masatsugu Kitakaze Masafumi

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 2, 2006-04 ,pp. : 93-102

Springer Publishing Company

Access to resources Recommend Favorite

Cellular mechanisms for the treatment of chronic heart failure: the nitric oxide- and adenosine-dependent pathways

By Kitakaze Masafumi Minamino Tetsuo

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 1, 2002-05 ,pp. : 99-110

Informa Healthcare

Access to resources Recommend Favorite

Role of nitric oxide in mediating cardiovascular alterations accompanying heart failure in rats

By Cunha Valdeci d. Stefanon Ivanita Mill José Geraldo

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 6, 2004-05 ,pp. : 372-379

NRC Research Press

Access to resources Recommend Favorite

Hydralazine: Duodenal melanosis in an elderly patient with chronic renal failure: case report

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Valsartan: In Chronic Heart Failure

By Wellington K. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite